Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung, and Other KK-LC-1 Positive Cancers

NCT05483491 is registered in ClinicalTrials.gov with Christian Hinrichs as lead sponsor.

NCT NCT05483491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05483491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung, and Other KK-LC-1 Positive Cancers
Lead sponsor
Christian Hinrichs
Phase
Phase 1
Overall status
Recruiting
Start date
September 26, 2022
Completion date
December 31, 2030
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, gastric cancer, lung cancer